Baldwin Wealth Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-330
| Closed | -$25.7K | – | 293 |
|
|
2024
Q3 | $25.7K | Sell |
330
-568
| -63% | -$44.3K | ﹤0.01% | 660 |
|
|
2024
Q2 | $70K | Buy |
898
+98
| +12% | +$7.64K | 0.01% | 299 |
|
|
2024
Q1 | $54.2K | Sell |
800
-287
| -26% | -$19.4K | ﹤0.01% | 357 |
|
|
2023
Q4 | $73.2K | Sell |
1,087
-2,780
| -72% | -$187K | 0.01% | 319 |
|
|
2023
Q3 | $262K | Hold |
3,867
| – | – | 0.02% | 199 |
|
|
2023
Q2 | $277K | Buy |
3,867
+156
| +4% | +$11.2K | 0.02% | 212 |
|
|
2023
Q1 | $258K | Buy |
3,711
+1,369
| +58% | +$95K | 0.02% | 217 |
|
|
2022
Q4 | $159K | Buy |
2,342
+1,243
| +113% | +$84.3K | 0.01% | 259 |
|
|
2022
Q3 | $61K | Buy |
1,099
+799
| +266% | +$44.3K | 0.01% | 305 |
|
|
2022
Q2 | $20K | Hold |
300
| – | – | ﹤0.01% | 471 |
|
|
2022
Q1 | $20K | Buy |
+300
| New | +$20K | ﹤0.01% | 476 |
|
|
2019
Q3 | – | Sell |
-105
| Closed | -$4K | – | 522 |
|
|
2019
Q2 | $4K | Buy |
+105
| New | +$4K | ﹤0.01% | 472 |
|